-- 
Astellas, Theravance Get EU Nod to Sell Vibativ for Pneumonia

-- B y   M a r t h e   F o u r c a d e
-- 
2011-09-15T07:08:44Z

-- http://www.bloomberg.com/news/2011-09-15/astellas-theravance-get-eu-nod-to-sell-vibativ-for-pneumonia.html
Astellas Pharma Inc. (4503)  and partner
 Theravance Inc. (THRX)  said they won European regulatory approval to
sell their medicine Vibativ for adults with hospital-acquired
pneumonia when other treatments failed.  To contact the editor responsible for this story:
Marthe Fourcade at 
 mfourcade@bloomberg.net  